drugset / Trial / NCT06726278
Significance of Misoprostol-induced Cervical Ripening Prior to Hysteroscopy
RandomizedParallel-groupQuadruple-blindHealth-services research
Summary
The goal of this prospective study is to evaluate the efficacy and safety of misoprostol for cervical ripening prior to hysteroscopy
Timeline
- Start
- 2022-08-01
- Primary completion
- 2024-07-30
- Completion
- 2024-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Misoprostol | Other / unclassified | 400 ug | Intrathecal |